Skip to main content

PaxLyte Prescribing Information

Package insert / product label
Generic name: multivitamin
Dosage form: capsule
Drug class: Vitamin and mineral combinations

Medically reviewed by Drugs.com. Last updated on Aug 8, 2024.

Warnings and Precautions

Folic Acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Daily doses of 0.1 mg or more of folic acid (vitamin B9) may obscure pernicious anemia. Hematologic improvement can occur while neurological damage progresses. Exclusive use of folic acid to treat vitamin B12-deficient macrocytic anemia can lead to progressive and irreversible neurological damage. Vitamin B12 deficiency allowed to progress for over 3 months may cause permanent spinal cord lesions. Doses of vitamin B12 exceeding 10 mcg daily may produce hematologic response in patients with vitamin B9 deficiency. Indiscriminate administration may mask the true diagnosis.

Adverse Reactions/Side Effects

Mild transient diarrhea, polycythemia vera, itching, transitory exanthema, feeling of swelling of entire body may occur with administration of vitamin B12. Allergic sensitization has been reported following both oral and parenteral administration of vitamin B9.

PaxLyte Description

PaxLyte is an orally administered prescription vitamin for therapeutic use formulated for patients who are under specific direction and monitoring of homocysteine (HCY) status by a physician. It is specifically formulated for patients with deficiencies in folate and vitamin B12, including those with genetic polymorphisms affecting homocysteine metabolism. A recent study+ suggested that PaxLyte was effective in lowering homocysteine levels in patients that are positive for MTHFR (methylenetetrahydrofolate reductase polymorphism).

+ ClinicalTrials.gov identifier: NCT02709668, Correlation of Clinical Response With Homocysteine Reduction During Therapy With Reduced B Vitamins in Patients with MDD Who Are Positive for MTHFR C677T or A1298C Polymorphism.

Indications and Usage for PaxLyte

PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B12 deficiency, and the PREVENTION of vitamin B12-cofactor deficiency, l-methylfolate.

MECHANISM OF ACTION

VITAMIN B12 [TREATMENT]; FOLATE [PREVENTION]; OTHER [SUPPLEMENTATION]; Vitamin B12 is essential for the synthesis of methionine from homocysteine - a reaction which also requires l-methylfolate as a necessary cofactor.

PaxLyte Dosage and Administration

The normal dose, is one capsule daily OR as directed by a licensed healthcare practioner; preferably on an empty stomach.

How is PaxLyte supplied

PaxLyte is an oval, brownish orange softgel capsule with imprint 7N3 (NDC 64661-217-30*).

* This product is a prescription-folate with or without other dietary ingredients that – due to increased folate levels (AUG 2 1973 FR 20750), requires an Rx on the label because of increased risk associated with masking of B12 deficiency (pernicious anemia). Due to the risk of obscuring pernicious anemia, this product requires licensed medical supervision, an Rx status, and a National Drug Code (NDC) or similarly-formatted product code, as required by pedigree reporting requirements and supply-chain control as well as in some cases, for insurance-reimbursement applications.

CONTAINS

Each PaxLyte Softgel Contains:

Adenosylcobalamin1 (vitamin B12 ) ..... 50 mcg

Folinic Acid (B9 vitamer)..... 2.5 mg

Folic Acid (B9 vitamer)..... 1 mg

L-Methylfolate Magnesium (B9 vitamer)..... 7 mg

OTHER INGREDIENTS: Olive oil, gelatin, glycerin, magnesium ascorbate, at least 20 mg Phosphatidylserine DHA Complex (Sharp-PS® Gold)2, yellow beeswax, sodium citrate, sunflower lecithin, citric acid, annatto extract, 1.5 mg elemental iron (as ferrous glycine cysteinate)3, zinc ascorbate, 1 mg magnesium l-threonate, natural orange flavor, piperine, CoQ10 (ubidecarenone), betaine, 25 mcg flavin adenine dinucleotide (reduced vitamin B3), 25 mcg nicotinamide adenosine dinucleotide hydride (reduced vitamin B2), 25 mcg pyridoxal 5’ phosphate (reduced vitamin B6), 25 mcg thiamine pyrophosphate (reduced vitamin B1).

1 Adenosylcobalamin is an active coenzyme form of Vitamin B12 found in the human body.

2 Contains at least 12 mg phosphatidylserine (PS) – of which approximately 6.4 mg as PS-DHA-Ca, and less than 1% EPA (<800 mcg PS-EPA-Ca).

3 Pure amino acid, cysteinated iron chelate. CONTAINS FISH/KRILL/SOY. No artificial colorants. No dairy, wheat, sugar or egg.

CONTAINS FISH/KRILL/SOY. No artificial colorants. No dairy, wheat, sugar or egg.

image description

PAXLYTE
leucovorin, folic acid, levomefolate magnesium, ferrous cysteine glycinate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium, phosphatidyl serine, pyridoxal 5-phosphate, flavin adenine dinucleotide, nadh, cobamamide, cocarboxylase (thiamine pyrophosphate), magnesium ascorbate, zinc ascorbate, magnesium l-threonate and betaine capsule capsule
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:64661-217
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LEUCOVORIN (UNII: Q573I9DVLP) (LEUCOVORIN - UNII:Q573I9DVLP) LEUCOVORIN2.5 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1 mg
LEVOMEFOLATE MAGNESIUM (UNII: 1VZZ62R081) (LEVOMEFOLIC ACID - UNII:8S95DH25XC) LEVOMEFOLIC ACID7 mg
FERROUS CYSTEINE GLYCINATE (UNII: 8B4OP7RK5N) (FERROUS CATION - UNII:GW89581OWR) FERROUS CYSTEINE GLYCINATE13.6 mg
1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM (UNII: 6WJM73T46K) (1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE - UNII:DVY07ILF1W) 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM6.4 mg
1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM (UNII: 9ABD9DRK7B) (1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE - UNII:C3019D8IIA) 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM800 ug
PHOSPHATIDYL SERINE (UNII: 394XK0IH40) (PHOSPHATIDYL SERINE - UNII:394XK0IH40) PHOSPHATIDYL SERINE12 mg
PYRIDOXAL PHOSPHATE ANHYDROUS (UNII: F06SGE49M6) (PYRIDOXAL PHOSPHATE ANHYDROUS - UNII:F06SGE49M6) PYRIDOXAL PHOSPHATE ANHYDROUS25 ug
FLAVIN ADENINE DINUCLEOTIDE (UNII: ZC44YTI8KK) (FLAVIN ADENINE DINUCLEOTIDE - UNII:ZC44YTI8KK) FLAVIN ADENINE DINUCLEOTIDE025 ug
NADH (UNII: 4J24DQ0916) (NADH - UNII:4J24DQ0916) NADH25 ug
COBAMAMIDE (UNII: F0R1QK73KB) (COBAMAMIDE - UNII:F0R1QK73KB) COBAMAMIDE50 ug
COCARBOXYLASE (UNII: Q57971654Y) (COCARBOXYLASE - UNII:Q57971654Y) COCARBOXYLASE25 ug
MAGNESIUM ASCORBATE (UNII: 0N1G678593) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID24 mg
ZINC ASCORBATE (UNII: 9TI35313XW) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ZINC ASCORBATE1 mg
MAGNESIUM L-THREONATE (UNII: 1Y26ZZ0OTM) (THREONIC ACID, L- - UNII:75B0PMW2JF) MAGNESIUM L-THREONATE1 mg
BETAINE (UNII: 3SCV180C9W) (BETAINE - UNII:3SCV180C9W) BETAINE500 mg
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID1.83 mg
SODIUM CITRATE (UNII: 1Q73Q2JULR) (SODIUM CATION - UNII:LYR4M0NH37) SODIUM CITRATE1.83 mg
Inactive Ingredients
Ingredient NameStrength
ANNATTO (UNII: 6PQP1V1B6O)
GELATIN (UNII: 2G86QN327L)
GLYCERIN (UNII: PDC6A3C0OX)
LECITHIN, SUNFLOWER (UNII: 834K0WOS5G)
OLIVE OIL (UNII: 6UYK2W1W1E)
PIPERINE (UNII: U71XL721QK)
WATER (UNII: 059QF0KO0R)
UBIDECARENONE (UNII: EJ27X76M46)
YELLOW WAX (UNII: 2ZA36H0S2V)
Product Characteristics
Colorbrown ((annatto)) Scoreno score
ShapeOVALSize14mm
FlavorImprint Code7N3
Contains
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:64661-217-3030 in 1 BOTTLE; Type 0: Not a Combination Product08/01/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/01/2024
Labeler - Jaymac Pharmaceuticals (830767260)
Registrant - Jaymac Pharmaceuticals (830767260)
Establishment
NameAddressID/FEIBusiness Operations
Ocean Healthcare Pvt Ltd873673519manufacture(64661-217)